316 related articles for article (PubMed ID: 38187072)
41. Circulating microRNAs as the Potential Diagnostic and Prognostic Biomarkers for Nasopharyngeal Carcinoma.
Le TAH; Lao TD
Genes (Basel); 2022 Jun; 13(7):. PubMed ID: 35885944
[TBL] [Abstract][Full Text] [Related]
42. Plasma microRNA expression signature involving miR-548q, miR-630 and miR-940 as biomarkers for nasopharyngeal carcinoma detection.
Zhuo X; Zhou W; Li D; Chang A; Wang Y; Wu Y; Zhou Q
Cancer Biomark; 2018; 23(4):579-587. PubMed ID: 30475754
[TBL] [Abstract][Full Text] [Related]
43. Identification of a 3-miRNA Signature Associated With the Prediction of Prognosis in Nasopharyngeal Carcinoma.
Zhou J; Zhang B; Zhang X; Wang C; Xu Y
Front Oncol; 2021; 11():823603. PubMed ID: 35155213
[TBL] [Abstract][Full Text] [Related]
44. Minicircle-oriP-miR-31 as a Novel EBNA1-Specific miRNA Therapy Approach for Nasopharyngeal Carcinoma.
Wu J; Tan X; Lin J; Yuan L; Chen J; Qiu L; Huang W
Hum Gene Ther; 2017 May; 28(5):415-427. PubMed ID: 28042945
[TBL] [Abstract][Full Text] [Related]
45. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
[TBL] [Abstract][Full Text] [Related]
46. MicroRNA profiling study reveals miR-150 in association with metastasis in nasopharyngeal carcinoma.
Yue PY; Ha WY; Lau CC; Cheung FM; Lee AW; Ng WT; Ngan RK; Yau CC; Kwong DL; Lung HL; Mak NK; Lung ML; Wong RN
Sci Rep; 2017 Sep; 7(1):12012. PubMed ID: 28931826
[TBL] [Abstract][Full Text] [Related]
47. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
48. Identification of miRNA/mRNA-Negative Regulation Pairs in Nasopharyngeal Carcinoma.
Liu M; Zhu K; Qian X; Li W
Med Sci Monit; 2016 Jun; 22():2215-34. PubMed ID: 27350400
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA-342 inhibits cell proliferation and invasion in nasopharyngeal carcinoma by directly targeting ZEB1.
Zhu X; Li W; Zhang R; Liu Y
Oncol Lett; 2018 Jul; 16(1):1298-1304. PubMed ID: 30061949
[TBL] [Abstract][Full Text] [Related]
50. Identification of methylated genes and miRNA signatures in nasopharyngeal carcinoma by bioinformatics analysis.
Wang Y; Zhao Q; Lan N; Wang S
Mol Med Rep; 2018 Apr; 17(4):4909-4916. PubMed ID: 29393436
[TBL] [Abstract][Full Text] [Related]
51. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
[TBL] [Abstract][Full Text] [Related]
52. Integrated mRNA and microRNA transcriptome sequencing characterizes sequence variants and mRNA-microRNA regulatory network in nasopharyngeal carcinoma model systems.
Szeto CY; Lin CH; Choi SC; Yip TT; Ngan RK; Tsao GS; Li Lung M
FEBS Open Bio; 2014; 4():128-40. PubMed ID: 24490137
[TBL] [Abstract][Full Text] [Related]
53. Molecular subtyping of nasopharyngeal carcinoma (NPC) and a microRNA-based prognostic model for distant metastasis.
Zhao L; Fong AHW; Liu N; Cho WCS
J Biomed Sci; 2018 Feb; 25(1):16. PubMed ID: 29455649
[TBL] [Abstract][Full Text] [Related]
54. A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.
Liu N; Cui RX; Sun Y; Guo R; Mao YP; Tang LL; Jiang W; Liu X; Cheng YK; He QM; Cho WC; Liu LZ; Li L; Ma J
Int J Cancer; 2014 Mar; 134(6):1359-68. PubMed ID: 23999999
[TBL] [Abstract][Full Text] [Related]
55. The pathological roles of BART miRNAs in nasopharyngeal carcinoma.
Lo AK; Dawson CW; Jin DY; Lo KW
J Pathol; 2012 Aug; 227(4):392-403. PubMed ID: 22431062
[TBL] [Abstract][Full Text] [Related]
56. Silencing of miRNA-148a by hypermethylation activates the integrin-mediated signaling pathway in nasopharyngeal carcinoma.
Li HP; Huang HY; Lai YR; Huang JX; Chang KP; Hsueh C; Chang YS
Oncotarget; 2014 Sep; 5(17):7610-24. PubMed ID: 25277193
[TBL] [Abstract][Full Text] [Related]
57. miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2.
Zhu HM; Jiang XS; Li HZ; Qian LX; Du MY; Lu ZW; Wu J; Tian XK; Fei Q; He X; Yin L
Cell Physiol Biochem; 2018; 49(4):1564-1576. PubMed ID: 30223264
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
[TBL] [Abstract][Full Text] [Related]
59. Comprehensive analysis of key genes associated with ceRNA networks in nasopharyngeal carcinoma based on bioinformatics analysis.
Xu Y; Huang X; Ye W; Zhang Y; Li C; Bai P; Lin Z; Chen C
Cancer Cell Int; 2020; 20():408. PubMed ID: 32863767
[TBL] [Abstract][Full Text] [Related]
60. Screening of key miRNAs and evaluation of their diagnostic and prognostic values in nasopharyngeal carcinoma.
Zhuo X; Zhou W; Ye H; Li D; Chang A; Wu Y; Zhou Q
Oncol Lett; 2019 Jun; 17(6):5803-5810. PubMed ID: 31186807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
